Evonik Evonik

X

Find Pelabresib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Pelabresib
Also known as: Cpi-0610, 1380087-89-7, Cpi 0610, (s)-2-(6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide, Chembl4303404, Cpi-232
Molecular Formula
C20H16ClN3O2
Molecular Weight
365.8  g/mol
InChI Key
GCWIQUVXWZWCLE-INIZCTEOSA-N
FDA UNII
U4017GUQ06

Pelabresib Anhydrous is the anhydrous form of pelabresib, a small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, pelabresib binds to the acetylated lysine recognition motifs on the bromodomain of BET proteins, thereby preventing the interaction between the BET proteins and acetylated histone peptides. This disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell growth. Characterized by a tandem repeat of two bromodomains at the N-terminus, the BET proteins (BRD2, BRD3, BRD4 and BRDT) are transcriptional regulators that play an important role during development and cellular growth.
1 2D Structure

Pelabresib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(4S)-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide
2.1.2 InChI
InChI=1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9,16H,10H2,1H3,(H2,22,25)/t16-/m0/s1
2.1.3 InChI Key
GCWIQUVXWZWCLE-INIZCTEOSA-N
2.1.4 Canonical SMILES
CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl
2.1.5 Isomeric SMILES
CC1=NOC2=C1C3=CC=CC=C3C(=N[C@H]2CC(=O)N)C4=CC=C(C=C4)Cl
2.2 Other Identifiers
2.2.1 UNII
U4017GUQ06
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cpi-0610

2.3.2 Depositor-Supplied Synonyms

1. Cpi-0610

2. 1380087-89-7

3. Cpi 0610

4. (s)-2-(6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide

5. Chembl4303404

6. Cpi-232

7. U4017guq06

8. Pelabresib

9. Cpi-267232

10. 2-[(4s)-6-(4-chlorophenyl)-1-methyl-4h-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide

11. Cpi0610

12. 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-isoxazolo(5,4-d)(2)benzazepin-4-yl)acetamide

13. 4h-isoxazolo(5,4-d)(2)benzazepine-4-acetamide, 6-(4-chlorophenyl)-1-methyl-, (4s)

14. Pelabresib [inn]

15. Pelabresib Anhydrous

16. Unii-u4017guq06

17. Gtpl9120

18. Schembl15926539

19. Dtxsid201022544

20. Bcp10741

21. Ex-a1612

22. Bdbm50510872

23. Nsc784856

24. S7853

25. Akos030526467

26. Zinc200480149

27. Cs-5592

28. Nsc-784856

29. Compound 10 [pmid: 26815195]

30. Ncgc00483135-01

31. As-73876

32. Bc177446

33. Hy-12863

34. J3.554.939k

35. Q27076907

36. 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide

37. 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[e]isoxazolo[5,4-c]azepin-4-yl)acetamide

38. 2-[(7s)-9-(4-chlorophenyl)-3-methyl-5-oxa-4,8-diazatricyclo[8.4.0.0(2),?]tetradeca-1(10),2(6),3,8,11,13-hexaen-7-yl]acetamide

39. 62g

2.4 Create Date
2012-07-23
3 Chemical and Physical Properties
Molecular Weight 365.8 g/mol
Molecular Formula C20H16ClN3O2
XLogP33
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass365.0931045 g/mol
Monoisotopic Mass365.0931045 g/mol
Topological Polar Surface Area81.5 Ų
Heavy Atom Count26
Formal Charge0
Complexity561
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY